https://www.medscape.com/viewarticle/985847
0
0
12/19/22 at 11:02pm
Organization
Medscape
Authors
The expanded indication for pafolacianine (Cytalux) follows an initial approval in November 2021 for use in patients with ovarian cancer.
Create an account
or login to join the discussion